Stimulation of Glucagon Like Peptide-1 Secretion in Enteroendocrine L cells.
10.4093/kdj.2009.33.6.458
- Author:
Byung Joon KIM
1
Author Information
1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Konyang University School of Medicine, Daejeon, Korea.
- Publication Type:Review
- Keywords:
Enteroendocrine cells;
Glucagon like peptide-1;
Taste receptor
- MeSH:
Eating;
Enteroendocrine Cells;
Fluorescent Antibody Technique;
Glucagon;
Glucagon-Like Peptide 1;
Glucose;
GTP-Binding Proteins;
Insulin;
Membranes;
Obesity;
Phenobarbital;
Plasma;
Tongue;
Transducin
- From:Korean Diabetes Journal
2009;33(6):458-463
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
GLP-1 (glucagon like peptide-1) is new anti-diabetic drug with a number of beneficial effects. It stimulates glucose dependant insulin secretion and restoration of beta cell mass through enhancement of islet mass. However, it is easily inactivated after being secreted from enteroendocrine L cells. Recent trial to increased GLP-1 is to directly stimulate L cells through its receptor located in the surface of L cell. Taste receptor in the apical surface of L cell is activated by various tastants contained in the food. Tongue perceives taste sense through the heterotrimeric G-protein (alpha-gustducin) and its downstream signaling cascades. Same taste receptors are also expressed in enteroendocrine cells. In duodenal L cell, alpha-gustducin was detected by immunofluorescence stainig at the luminal projections of enteroendocrine cells. And several other taste signaling elements were also found in L cells. Ingestion of sweet or bitter compounds revealed stimulation of GLP-1 secretion and the regulation of plasma insulin and glucose. In this review, I will briefly introduce the possibilities to stimulate GLP-1 secretion though the membrane receptor in enteroendocrine cell. And it will be the good candidate to develop the treatment modality for obesity, diabetes and abnormal gut motility.
